Assessment of exposure to bovine spongiform encephalopathy in a hypothetical country

OIE Revue Scientifique et Technique

Volumn 29, Issue 3, 2010, Pages 459-471

  Hutter, S E ^a   Kihm, U ^a  

^a Safe Food Solutions Inc   (Switzerland)

Author keywords

Bovine spongiform encephalopathy; Bse cycle; Cattle; Exposure assessment; Implementation of laws; Latin america; Risk assessment; Spreadsheet model

Indexed keywords

ANIMALIA; BOS; BOVINAE;

EID: 79951589491     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.29.3.1990     Document Type: Article

References (21)

1. Arnold M.E. & Wilesmith J.W. (2004). - Estimation of the age-dependent risk of infection to BSE of dairy cattle in Great Britain. Prev. vet. Med., 66 (1-4), 35-47. (Pubitemid 39569133)
2. Bradley R. (2002). - Bovine spongiform encephalopathy. Update. Acta Neurobiol. Exp., 62 (3), 183-195.
3. Comer P.J. & Huntly P.J. (2004). - Exposure of the human population to BSE infectivity over the course of the BSE epidemic in Great Britain and the impact of changes to the Over Thirty Month Rule. J. Risk Res., 7 (5), 523-543.
4. Doherr M.G., Heim D., Vandevelde M. & Fatzer R. (1999). - Modelling the expected numbers of preclinical and clinical cases of bovine spongiform encephalopathy in Switzerland. Vet. Rec., 145 (6), 155-160. (Pubitemid 129544072)
5. European Food Safety Authority (EFSA) (2005). - EFSA QRA Report 2004 - working document. EFSA J., 307, 1-135. Available at: www.efsa.europa.eu/EFSA/ Scientific-Document/efsaqrareport2004-final20dec051.pdf (accessed on 11 January 2008).
6. European Food Safety Authority (EFSA) (2005). - Opinion of the Scientific Panel on Biological Hazards (BIOHAZ) on the 'Assessment of the human and animal BSE risk posed by tallow with respect to residual BSE risk'. EFSA J., 221, 1-47. Available at: www.efsa europa eu/EFSA/efsalocale-1178620753812-1178620776 706.htm (accessed on 18 February 2009).
7. European Food Safety Authority (EFSA) (2007). - Opinion of the Scientific Panel on Biological Hazards (BIOHAZ) on the revision of the geographical BSE risk assessment. EFSA J., 463, 1-35. Available at: www.efsa europa.eu/cs/ BlobServer/Scientific-Opinion/biohaz-op-ej463-gbr-revision-en.pdf?ss binary=true (accessed on 24 January 2009).
8. Grist E.P.M. (2005). - Transmissible spongiform encephalopathy risk assessment: the UK experience. Risk Anal., 25 (3), 519-532.
9. Heim D., Gardner I., Mumford E. & Kihm U. (2006). - Risk assessment and surveillance for bovine spongiform encephalopathy. Rev. sci. tech Off. int. Epiz., 25 (3), 937-950. (Pubitemid 46360193)
10. Kim T.Y., Kim Y.S., Kim J K., Shon H.J., Lee Y.H., Kang C.B., Park J.S., Kang K.S. & Lee Y.S. (2005). - Risk analysis of bovine spongiform encephalopathy in Korea. J. vet. med. Sci., 67 (8), 743-752.
11. Morley R.S., Chen S. & Rheault N. (2003). - Assessment of the risk factors related to bovine spongiform encephalopathy. In Risk analysis of prion diseases in animals (C.I. Lasmézas & D.B. Adams, eds). Rev. sci. tech. Off. int. Epiz., 22 (1), 157-178.
12. Ovelhey A., Beyerbach M., Schael J., Selhorst T., Kramer M. & Kreienbock L. (2008). - Risk factors for BSE-infections in Lower Saxony, Germany. Prev. vet. Med., 83 (2), 196-209. E-pub.: 30 August 2007.
13. Paisley L.G. & Hostrup-Pedersen J. (2004). - A quantitative assessment of the risk of transmission of bovine spongiform encephalopathy by tallow-based calf milk-replacer. Prev. vet. Med., 63 (1-2), 135-149.
14. Prince M.J., Bailey J A., Barrowman P.R., Bishop K.J., Campbell G.R. & Wood J.M. (2003). - Bovine spongiform encephalopathy. In Risk analysis of prion diseases in animals (CI. Lasmézas & D.B. Adams, eds). Rev. sci. tech. Off. int. Epiz., 22 (1), 37-60.
15. Taylor D.M. & Woodgate S.L. (1997). - Bovine spongiform encephalopathy: the causal role of ruminant-derived protein in cattle diets. In Contamination of animal products: prevention and risks for animal health (R Sutmoller, ed.). Rev. sci. tech. Off. int. Epiz., 16 (1), 187-198.
16. Taylor D.M., Woodgate S.L. & Atkinson M.J. (1995). - Inactivation of the bovine spongiform encephalopathy agent by rendering procedures. Vet. Rec., 137 (24), 605-610.
17. Wells G.A.H., Konoid T., Arnold M.E., Austin R.A., Hawkins S.A.C., Stack M., Simmons M.M., Lee Y.H., Gavier-Widén D., Dawson M. & Wilesmith J.W. (2007). - Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle. J. gen. Virol., 88, 1363-1373. (Pubitemid 46523528)
18. Wells G.A.H., Spiropoulos J., Hawkins S.A.C. & Ryder S.J. (2005). - Pathogenesis of experimental bovine spongiform encephalopathy: preclinical infectivity in tonsil and observations on the distribution of lingual tonsil in slaughtered cattle. Vet. Rec., 156 (13), 401-407. (Pubitemid 40520838)
19. Wilesmith J.W, Ryan J.B.M. & Hueston WD. (1992). - Bovine spongiform encephalopathy: case-control studies of calf feeding practices and meat and bonemeal inclusion in proprietary concentrates. Res. vet. Sci., 52 (3), 325-331.
20. World Organisation for Animal Health (OIE) (2008). - Chapter 11.6. Bovine spongiform encephalopathy. In Terrestrial Animal Health Code. OIE, Paris. Available at: www.oie.int/eng/normes/mcode/en-chapitre-1.11.6.pdf (accessed on 30 October 2008).
21. Yoshikawa Y. (2008). - Epidemiological study on BSE outbreak in Japan. J. vet. med. Sci., 70 (4), 325-336.